Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Agios Pharmaceuticals, Inc. (AGIO) had Income from Continuous Operations of $-112.02M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$12.46M |
|
$-112.02M |
|
$1.70M |
|
$10.75M |
|
$139.51M |
|
$-127.06M |
|
$15.04M |
|
$-112.02M |
|
$-112.02M |
|
$-112.02M |
|
|
Income from Continuous Operations |
$-112.02M |
$-112.02M |
|
$-112.02M |
|
$-127.06M |
|
$-128.22M |
|
57.93M |
|
57.93M |
|
$-1.93 |
|
$-1.93 |
|
| Balance Sheet Financials | |
$1.02B |
|
$10.58M |
|
$451.77M |
|
$1.47B |
|
$70.41M |
|
-- |
|
$31.27M |
|
$101.68M |
|
$1.37B |
|
$1.37B |
|
$1.37B |
|
58.04M |
|
| Cash Flow Statement Financials | |
$-188.61M |
|
$191.55M |
|
$1.68M |
|
$76.25M |
|
$80.87M |
|
$4.62M |
|
$26.05M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.48 |
|
-- |
|
-- |
|
-- |
|
-- |
|
86.33% |
|
-1020.12% |
|
-1020.12% |
|
-- |
|
-899.40% |
|
-899.40% |
|
$-190.25M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
0.06 |
|
2.50 |
|
36.03 |
|
-8.18% |
|
-8.18% |
|
-7.61% |
|
-8.18% |
|
$23.60 |
|
$-3.28 |
|
$-3.26 |
|